Innovation In Real World Data Collection

By Tricia Seitzer, Consultant, Pricing & Market Access

Leaders from payer organisations and the pharma industry were abuzz with visions of the future at the recent co-located Evidence Europe Congress and World Pharma Pricing and Market Access Congress.

The conversation was framed with an acknowledgement that healthcare systems across the globe face a number of key challenges, including growing deficits, elderly populations, longer life spans and rising healthcare costs. Central to the discussion were the need for solutions that ensure patient have access to truly innovative treatments, while simultaneously meeting tight budget constraints.  

It is clear that across the industry, intelligent data, meaning data that can be leveraged to make more informed decisions, and early planning for payer evidence generation, are integral to the solution. There is a plethora of data available currently, but intelligent integrated data needs to be designed to make a difference; this can come in diverse forms- many of which were explored in the conferences.